New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients Post author: Post published:November 23, 2023 Post category:uncategorized Bivalent booster dose enhanced neutralization of Omicron XBB (sub)variants in non-small cell lung cancer (NSCLC) patients. You Might Also Like Toddler’s backyard snakebite bills totaled more than a quarter million dollars October 30, 2024 Hidden brain changes found to common in people with a range of heart conditions March 26, 2024 Study demonstrates safe reduction of lymph node removal in breast cancer patients March 22, 2024